Terry L Mashtare Jr
Overview
Explore the profile of Terry L Mashtare Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hutson A, Mashtare Jr T, Mudholkar G
Commun Stat Theory Methods
. 2020 Sep;
49(17):4197-4215.
PMID: 32913381
The log-normal distribution is widely used to model non-negative data in many areas of applied research. In this paper, we introduce and study a family of distributions with non-negative reals...
2.
Likness M, Pallanch J, Sherris D, Kita H, Mashtare Jr T, Ponikau J
Otolaryngol Head Neck Surg
. 2013 Dec;
150(2):305-11.
PMID: 24301090
Objectives: A truly objective method of measuring disease severity in chronic rhinosinusitis (CRS) has only recently existed. We evaluated computed tomography (CT) scans of CRS patients using this novel objective...
3.
Fallavollita J, Heavey B, Luisi Jr A, Michalek S, Baldwa S, Mashtare Jr T, et al.
J Am Coll Cardiol
. 2013 Oct;
63(2):141-9.
PMID: 24076296
Objectives: The PAREPET (Prediction of ARrhythmic Events with Positron Emission Tomography) study sought to test the hypothesis that quantifying inhomogeneity in myocardial sympathetic innervation could identify patients at highest risk...
4.
Chanan-Khan A, Chitta K, Ersing N, Paulus A, Masood A, Sher T, et al.
Br J Haematol
. 2011 Oct;
155(4):457-67.
PMID: 22010965
Lenalidomide has demonstrated impressive antileukaemic effects in patients with chronic lymphocytic leukaemia (CLL). The mechanism(s) by which it mediates these effects remain unclear. Clinically, CLL patients treated with lenalidomide demonstrate...
5.
McCloskey S, Jaggernauth W, Rigual N, Hicks Jr W, Popat S, Sullivan M, et al.
Am J Clin Oncol
. 2009 Jul;
32(6):587-91.
PMID: 19581794
Purpose: To determine whether baseline hemoglobin level and radiation treatment interruptions predict for loco-regional failure after intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for definitive treatment of squamous cell carcinoma...